Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Varex Imaging (VREX) EBT (2016 - 2026)

Varex Imaging (VREX) has disclosed EBT for 11 consecutive years, with $3.8 million as the latest value for Q1 2026.

  • On a quarterly basis, EBT rose 52.0% to $3.8 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$56.3 million, a 860.81% decrease, with the full-year FY2025 number at -$59.2 million, down 1284.0% from a year prior.
  • EBT was $3.8 million for Q1 2026 at Varex Imaging, down from $12.7 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $17.1 million in Q2 2023 to a low of -$87.6 million in Q3 2025.
  • A 5-year average of $1.4 million and a median of $4.6 million in 2022 define the central range for EBT.
  • Biggest YoY gain for EBT was 825.0% in 2025; the steepest drop was 11050.0% in 2025.
  • Varex Imaging's EBT stood at $5.4 million in 2022, then tumbled by 122.22% to -$1.2 million in 2023, then soared by 308.33% to $2.5 million in 2024, then surged by 408.0% to $12.7 million in 2025, then tumbled by 70.08% to $3.8 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's EBT are $3.8 million (Q1 2026), $12.7 million (Q4 2025), and -$87.6 million (Q3 2025).